HOT mutation screening in human glioblastomas

Daniel Krell, Paul Mulholland, Justin Stebbing, Ian Tomlinson, Chiara Bardella

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


AIMS: Somatic mutations in IDH1 and IDH2 are described in glioblastomas (GBMs). Mutant IDH1 and IDH2 reduce α-KG to D-2HG which accumulates, and is proposed to promote tumorigenesis. HOT catalyzes the conversion of γ-hydroxybutyrate to succinic semialdehyde in a reaction that produces D-2HG. Since increased HOT enzyme activity could lead to an accumulation of D-2HG, coupled with the fact that only a minority of GBMs carry IDH1/2 mutations and 2HG accumulation has recently been described in IDH wild-type tumors, we analyzed a set of GBM samples for mutations in the HOT gene.

MATERIALS & METHODS: We screened 42 human GBM samples for mutations in HOT.

RESULTS: No mutations in HOT were identified in the 42 GBM samples screened.

CONCLUSION: Mutations in the coding regions of HOT do not occur at an appreciable frequency in GBM.

Original languageEnglish
JournalFuture Oncology
Issue number3
Early online date17 Jun 2015
Publication statusPublished - Nov 2015


Dive into the research topics of 'HOT mutation screening in human glioblastomas'. Together they form a unique fingerprint.

Cite this